Clinical Trials in Houston

Showing 861-880 of 8,625 trials

Study to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Generalized Myasthenia Gravis

NCT06704269

This is a phase I/II study to assess safety, efficacy, and cellular kinetics of YTB323 in participants with treatment-resistant generalized myasthenia gravis. YTB323 is a Biological CAR-T cell therapy.

Generalized Myasthenia Gravis

Novartis Pharmaceuticals15 participantsStarted Apr 2025

Orange, California, United States • Winston-Salem, North Carolina, United States • Houston, Texas, United States +7 more locations

TERMINATEDPHASE2< 1 mile

A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF)

NCT05592275

The main purpose of this study is to assess the efficacy and safety of LY3540378 in adults with worsening heart failure with preserved ejection fraction

Heart FailureHeart Failure With Preserved Ejection Fraction

Eli Lilly and Company332 participantsStarted Feb 2023

Tucson, Arizona, United States • Covina, California, United States • Northridge, California, United States +134 more locations

Study to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Generalized Myasthenia Gravis

A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF)

Find Trials by Condition in Houston

A Study of Efficacy, Safety, Tolerability of LXE408 in Participants With Chronic Chagas Disease.

A Study of MGC026 in Participants With Advanced Solid Tumors

A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)

A Study of AL102 in Patients With Progressing Desmoid Tumors

Randomized Study of the pdSTIM™ System in Failure to Wean Mechanically Ventilated Patients

Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Rate of Progression in USH2A-related Retinal Degeneration

A Study of Avoralstat In Participants With Diabetic Macular Edema

A Study to Learn About the Study Medicine Called PF-07976016 in Adults With Obesity

Efficacy and Safety of MK-8189 in Participants With an Acute Episode of Schizophrenia (MK-8189-008)

Study of First-line Pembrolizumab (MK-3475) With Lenvatinib (MK-7902/E7080) in Urothelial Carcinoma Cisplatin-ineligible Participants Whose Tumors Express Programmed Cell Death-Ligand 1 and in Participants Ineligible for Platinum-containing Chemotherapy (MK-7902-011/E7080-G000-317/ LEAP-011)

Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis

A Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast Cancer

64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)

Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study

Postmarketing Prospective Study of Melanoma Patients Treated With IMLYGIC® to Characterize Risk of Herpetic Infection

International CRDS Registry